Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 18
2003 7
2004 12
2005 16
2006 11
2007 11
2008 17
2009 16
2010 9
2011 7
2012 7
2013 7
2014 11
2015 12
2016 14
2017 10
2018 12
2019 9
2020 7
2021 11
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
NOP-Targeted Peptide Ligands.
Preti D, Caló G, Guerrini R. Preti D, et al. Among authors: guerrini r. Handb Exp Pharmacol. 2019;254:17-36. doi: 10.1007/164_2018_198. Handb Exp Pharmacol. 2019. PMID: 30689091
Novel Mixed NOP/Opioid Receptor Peptide Agonists.
Pacifico S, Albanese V, Illuminati D, Marzola E, Fabbri M, Ferrari F, Holanda VAD, Sturaro C, Malfacini D, Ruzza C, Trapella C, Preti D, Lo Cascio E, Arcovito A, Della Longa S, Marangoni M, Fattori D, Nassini R, Calò G, Guerrini R. Pacifico S, et al. Among authors: guerrini r. J Med Chem. 2021 May 27;64(10):6656-6669. doi: 10.1021/acs.jmedchem.0c02062. Epub 2021 May 17. J Med Chem. 2021. PMID: 33998786 Free PMC article.
Neuropeptide S receptor ligands: a patent review (2005-2016).
Ruzza C, Calò G, Di Maro S, Pacifico S, Trapella C, Salvadori S, Preti D, Guerrini R. Ruzza C, et al. Among authors: guerrini r. Expert Opin Ther Pat. 2017 Mar;27(3):347-362. doi: 10.1080/13543776.2017.1254195. Epub 2016 Nov 9. Expert Opin Ther Pat. 2017. PMID: 27788040 Review.
Nociceptin/Orphanin FQ and Urinary Bladder.
Angelico P, Barchielli M, Lazzeri M, Guerrini R, Caló G. Angelico P, et al. Among authors: guerrini r. Handb Exp Pharmacol. 2019;254:347-365. doi: 10.1007/164_2018_182. Handb Exp Pharmacol. 2019. PMID: 30430260
Pharmacological profile of nociceptin/orphanin FQ receptors.
Calo' G, Rizzi A, Bigoni R, Guerrini R, Salvadori S, Regoli D. Calo' G, et al. Among authors: guerrini r. Clin Exp Pharmacol Physiol. 2002 Mar;29(3):223-8. doi: 10.1046/j.1440-1681.2002.03633.x. Clin Exp Pharmacol Physiol. 2002. PMID: 11906488 Review.
Solution structure of nociceptin peptides.
Amodeo P, Guerrini R, Picone D, Salvadori S, Spadaccini R, Tancredi T, Temussi PA. Amodeo P, et al. Among authors: guerrini r. J Pept Sci. 2002 Sep;8(9):497-509. doi: 10.1002/psc.412. J Pept Sci. 2002. PMID: 12371703 Review.
205 results